As employee inventors continue to file more patents with the Patent office, it’s important that you encourage them to do the same within your company. There are many ways in which a company can encourage its employee inventors to file for more patents. If you’re ready to help your company get even more value out of your employee inventor program, you should follow these tips. Read More Continue Reading How to Encourage Employee Inventors in Your Company to File for…
A patent attorney’s job includes tracking and managing deadlines and schedules for each patent case that he or she handles. Every Indian patent has at least ten (10) deadlines on average, and a patent attorney managing a portfolio of one hundred patents must keep track of at least one thousand dates. Read More Continue Reading Can you revive abandoned/lapsed patents and patent applications in India?
One of the critical parts of a patent attorney’s work is the management of timelines and deadlines relating to patent files being handled by her/him. On an average, each patent file in India has at least ten (10) deadlines, and if a patent attorney has a portfolio of 100 patents, she/he is looking at at least 1000 dates to track. Read More Continue Reading Role of ‘Intent’ in Reviving lost Patents and Patent Applications in India
When you’re launching a new product, service, or marketing plan, it’s easy to get caught up in the excitement and forget about all the pitfalls that lie ahead. An intellectual property audit is an excellent way to identify potential IP opportunities and risks before they become real problems. Read More.. Continue Reading Why Perform an IP Audit? 5 Reasons
If you’ve come up with an idea for a new product, you might be wondering if it’s worth filing a patent to protect that idea. After all, patents can be expensive to obtain and challenging to understand. Do you really need one? The answer is probably yes. Read More Continue Reading 5 Reasons Why You Should File Patents Over Your Inventions
A patent search will tell you if any patents cover similar products to yours – and therefore whether or not your idea is patentable. To qualify for a Patent your invention must have “novelty” and “non-obviousness”. This means that it must not be similar to any existing products, and it must also be a significant improvement on anything that’s been produced before. Read More Continue Reading 5 Reasons to Conduct a Patent Search
Safex Chemical India Ltd vs The Controller Of Patents And another
In this case, Safex Chemical India Limited (“Safex”) filed a writ petition before the Bombay High Court with respect to the denial of the opportunity to respond to amendments in a pre-grant opposition. The patent application in the case is related to the chemical composition for increasing crop yield. Read More Continue Reading You Shouldn’t have filed a Post-Grant Opposition, says Bombay High Court
Facts (with Timeline):
i) FMC Corporation and FMC Agro Singapore Pte. Ltd. (collectively referred to as “Plaintiffs”) were assigned Indian Patent No. 298645 (suit patent/IN’645) titled “Method for preparing N-Phenylpyrazole-1-Carboxamides.”
ii) The suit patent disclosed a novel method for preparing anthranilic diamide insecticide compounds. The claimed method involves combining:
a carboxylic acid compound of Formula 2,
an aniline compound of Formula 3, and
a sulfonyl chloride,
to prepare a compound of Formula 1 (Chlorantraniliprole (CTPR)).
iii) The Plaintiffs brought…
In a recent case involving Gogoro Inc, the Delhi High Court remanded a patent decision back to the patent office on the ground that the order was unreasoned. The Controller of Patents in the case rejected the patent application filed by Gogoro Inc relating to a power charging system on the ground that it lacked inventive step. The Controller cited three prior art references but failed to explain how a person skilled in the art would arrive at the claimed…
Boehringer Ingelheim International GMBH vs The Controller Of Patents & Anr. on 12 July, 2022
Delhi High Court
Facts / Background
The Applicant, Boehringer Ingelheim International GMBH, had filed a National Phase PCT Application on 14th November, 2008, for 'Use of IV Inhibitors'. The patent specification had Claims numbered 1 - 18, with two claims numbered as 15, which were referred to as 15 and 15A.
The First Examination Report ("FER") was issued on 24th March, 2014, in response to…